Line 127: |
Line 127: |
| == Assay Design Rates == | | == Assay Design Rates == |
| | | |
− | {| border="1" align="center" cellpadding="1" cellspacing="1" summary="Summarizes the Number of SNPs in Each Category That Passed Assay Design. Note that Categories Overlap." | + | {| align="left" cellpadding="2" cellspacing="1" summary="Summarizes the Number of SNPs in Each Category That Passed Assay Design. Note that Categories Overlap." |
− | |+ Illumina Assay Design Summary | + | |+ Illumina Assay Design Summary |
| |- | | |- |
− | ! scope="col" | SNP Set | + | ! scope="col" | SNP Set |
− | ! scope="col" | Number of <br>Candidates | + | ! scope="col" align = "center" | Number of <br>Candidates |
− | ! scope="col" | Number of <br>Successful Designs | + | ! scope="col" align = "center" | Number of <br>Successful Designs |
− | ! scope="col" | Additional <br>Notes | + | ! scope="col" align = "center" | Additional Notes |
| |- | | |- |
− | ! scope="row" | Coding Content | + | ! scope="row" | Coding Content |
− | | 275,165 | + | | align="right" | 275,165 |
− | | 243,094 | + | | align="right" | 243,094 |
− | | An additional set of 8,242 SNPs that were unique to the 1000 Genomes Project and populations under-represented in the design was added. | + | | An additional set of 8,242 SNPs that were unique to the 1000 Genomes Project and populations under-represented in the design was added. |
| |- | | |- |
− | ! scope="row" | GWAS Tag SNPs | + | ! scope="row" | GWAS Tag SNPs |
− | | 5,763 | + | | align="right" | 5,763 |
− | | 5,325 | + | | align="right" | 5,325 |
| | | | | |
| |- | | |- |
− | ! scope="row" | Grid of Common Variants | + | ! scope="row" | Grid of Common Variants |
− | | 5,710 | + | | align="right" | 5,710 |
− | | 5,286 | + | | align="right" | 5,286 |
| | | | | |
| |- | | |- |
− | ! scope="row" | Randonly Selected Synonymous SNPs | + | ! scope="row" | Randonly Selected Synonymous SNPs |
− | | 5,000 | + | | align="right" | 5,000 |
− | | 4,651 | + | | align="right" | 4,651 |
− | | For 1,000 SNPs, assays were generated on both strands - to faciliate QC efforts and future development of methods for genotyping of rare variants. | + | | For 1,000 SNPs, assays were generated on both strands - to faciliate QC efforts and future development of methods for genotyping of rare variants. |
| |- | | |- |
− | ! scope="row" | AIM - African Ancestry | + | ! scope="row" | AIM - African Ancestry |
− | | 3,388 | + | | align="right" | 3,388 |
− | | 3,241 | + | | align="right" | 3,241 |
| | | | | |
| |- | | |- |
− | ! scope="row" | AIM - Native American Ancestry | + | ! scope="row" | AIM - Native American Ancestry |
− | | 1,000 | + | | align="right" | 1,000 |
− | | 998 | + | | align="right" | 998 |
| | | | | |
| |- | | |- |
− | ! scope="row" | HLA Tags | + | ! scope="row" | HLA Tags |
− | | 2,536 | + | | align="right" | 2,536 |
− | | 2,459 | + | | align="right" | 2,459 |
| | | | | |
| |- | | |- |
− | ! scope="row" | ESP Requests | + | ! scope="row" | ESP Requests |
− | | 1,003 | + | | align="right" | 1,003 |
− | | 843 | + | | align="right" | 843 |
| | | | | |
| |- | | |- |
− | ! scope="row" | Fingerprint SNPs | + | ! scope="row" | Fingerprint SNPs |
− | | 285 | + | | align="right" | 285 |
− | | 259 | + | | align="right" | 259 |
| | | | | |
| |- | | |- |
− | ! scope="row" | MicroRNA Target Sites | + | ! scope="row" | MicroRNA Target Sites |
− | | 285 | + | | align="right" | 285 |
− | | 270 | + | | align="right" | 270 |
| | | | | |
| |- | | |- |
− | ! scope="row" | Mitochondrial Variants | + | ! scope="row" | Mitochondrial Variants |
− | | 246 | + | | align="right" | 246 |
− | | 246 | + | | align="right" | 246 |
| | | | | |
| |- | | |- |
− | ! scope="row" | Chromosome Y | + | ! scope="row" | Chromosome Y |
− | | 188 | + | | align="right" | 188 |
− | | 128 | + | | align="right" | 128 |
| | | | | |
| |- | | |- |
− | ! scope="row" | Indels | + | ! scope="row" | Indels |
− | | 181 | + | | align="right" | 181 |
− | | 181 | + | | align="right" | 181 |
− | | | |
− | |-
| |
− | ! scope="row" |
| |
− | |
| |
− | |
| |
− | |
| |
| |} | | |} |